Investor Presentaiton slide image

Investor Presentaiton

Group Financial Results for the six months ended 30 June 2021 1H2021 - Highlights Strong Recovery Underway Positive Operating Performance €894 m n New lending €57 mn Operating Profit • 12.9% GDP growth in 2Q2021 • • • Continuing to support this recovery; new lending of €894 mn in 1H2021, up 30% yoy Tourism demonstrating signs of recovery; July 2021 arrivals +358% yoy or 54% of July 2019 levels • 78% of adult population in Cyprus vaccinated with first dose¹ and 74% have completed their vaccination regime • • Total income of €152 mn for 2Q2021, up 11% qoq Cost of risk of 52 bps for 2Q2021, improved by 14 bps qoq Profit after tax and before non-recurring items of €34 mn for 2Q2021 and €51 mn for 1H2021 After recognising exceptional costs, loss after tax of €7 mn for 2Q2021 and profit after tax of €1 mn for 1H2021 Operating Efficiency Good Capital Strong Liquidity Balance Sheet Repair Continuing 1) Data as at 28 August 2021 (Source: Ministry of Health) 2) Excluding special levy on deposits and other levies/contributions. Bank of Cyprus Holdings 58% Cost/Income² 14.2% CET1 ratio³ 6.4% Net NPE ratio • Total operating expenses² of €89 mn for 2Q2021, up 7% qoq reflecting seasonality in prior quarter Cost to income ratio² at 58% for 2Q2021, down 2 p.p. qoq • • CET1 ratio of 14.2%³ and Total Capital ratio of 19.2%3 • . MREL interim requirement as of 1 Jan 2022 already achieved through the successful refinancing of Tier 2 and the inaugural issuance of Senior Preferred notes in 2Q2021 Deposits at €16.8 bn, up 3% qoq; Significant surplus liquidity of €5.7 bn (LCR at 303%) . €1.3 bn NPE sale (Helix 2 Portfolios A and B) completed in 2Q2021 • NPES at €1.6 bn (€0.6 bn net) • Gross NPE ratio reduced to 14.6% (6.4% net); organic NPE reduction of €171 mn in 1H2021 Coverage improved to 60% over the quarter • 96% of performing loans under expired payment deferrals with an instalment due by 12 Aug 2021, presented no arrears 3) 4) Allowing for IFRS 9 and temporary treatment for certain FVOCI instruments transitional arrangements As at 30 June 2021 4
View entire presentation